mFOLFOX6 trials for Colorectal cancer
All mFOLFOX6 trials · All Colorectal cancer trials
7
Recruiting trials
Phase breakdown
Phase 1 2Phase 2 3Phase 3 3
Recruiting trials studying mFOLFOX6 for Colorectal cancer
- BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer
- Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
- Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
- Total Neoadjuvant Therapy in Rectal Cancer
- mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
Common questions
How many trials study mFOLFOX6 for Colorectal cancer?
7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.